Immunopathologic role of B lymphocytes in rheumatoid arthritis: Rationale of B cell-directed therapy

Autoimmunity Reviews

Volumn 5, Issue 7, 2006, Pages 437-442

  Martinez Gamboa, Lorena ^a   Brezinschek, Hans Peter ^b   Burmester, Gerd R ^a   Dörner, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

B cell directed therapies; B lymphocytes; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; BELIMUMAB; CD20 ANTIBODY; CYTOKINE; EPRATUZUMAB; RITUXIMAB;

ADOPTIVE IMMUNOTHERAPY; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL FUNCTION; CLINICAL TRIAL; CYTOKINE PRODUCTION; FOLLICULAR DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; JOINT DESTRUCTION; LYMPHOID ORGAN; MEMORY CELL; NONHODGKIN LYMPHOMA; NONHUMAN; ORGANOGENESIS; PATHOGENESIS; PLASMA CELL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION;

ANIMALS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; HUMANS;

EID: 33747203086     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.02.004     Document Type: Review

References (31)

1. Firestein G.S., and Zvaifler N.J. How important are T cells in chronic rheumatoid synovitis?. Arthritis Rheum 33 6 (1990) 768-773
2. Smolen J.S., and Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov 2 6 (2003) 473-488
3. Edwards J.C., Szczepanski L., Szechinski J., Filipowicz-Sosnowska A., Emery P., Close D.R., et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350 25 (2004) 2572-2581
4. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37 8 (2005) 820-828
5. Protheroe A., Edwards J.C., Simmons A., Maclennan K., and Selby P. Remission of inflammatory arthropathy in association with anti-CD20 therapy for non-Hodgkin's lymphoma. Rheumatology 38 11 (1999) 1150-1152
6. Stewart M., Malkovska V., Krishnan J., Lessin L., and Barth W. Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab. Ann Rheum Dis 60 9 (2001) 892-893
7. Baecklund E., Sundstrom C., Ekbom A., Catrina A.I., Biberfeld P., Feltelius N., et al. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48 6 (2003) 1543-1550
8. Serreze D.V., and Silveira P.A. The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes. Curr Dir Autoimmun 6 (2003) 212-227
9. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 6881 (2002) 603-607
10. Golovkina T.V., Shlomchik M., Hannum L., and Chervonsky A. Organogenic role of B lymphocytes in mucosal immunity. Science 286 5446 (1999) 1965-1968
11. Matsumoto M., Lo S.F., Carruthers C.J., Min J., Mariathasan S., Huang G., et al. Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature 382 6590 (1996) 462-466
12. Horneff G., Emmrich F., and Burmester G.R. Advances in immunotherapy of rheumatoid arthritis: clinical and immunological findings following treatment with anti-CD4 antibodies. Br J Rheumatol 32 Suppl 4 (1993) 39-47
13. Dorner T., and Burmester G.R. The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr Opin Rheumatol 15 3 (2003) 246-252
14. Schellekens G.A., de Jong B.A., van den Hoogen F.H., van de Putte L.B., and van Venrooij W.J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101 1 (1998) 273-281
15. Genevay S., Hayem G., Verpillat P., and Meyer O. An eight year prospective study of outcome prediction by antiperinuclear factor and antikeratin antibodies at onset of rheumatoid arthritis. Ann Rheum Dis 61 8 (2002) 734-736
16. Carroll M.C. The complement system in regulation of adaptive immunity. Nat Immunol 5 10 (2004) 981-986
17. Carroll M.C. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 4 10 (2004) 825-831
18. Vossenaar E.R., Smeets T.J., Kraan M.C., Raats J.M., van Venrooij W.J., and Tak P.P. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 50 11 (2004) 3485-3494
19. Lund F.E., Garvy B.A., Randall T.D., and Harris D.P. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr Dir Autoimmun 8 (2005) 25-54
20. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., and Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3 10 (2002) 944-950
21. Henneken M., Dorner T., Burmester G.R., and Berek C. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 7 5 (2005) R1001-R1013
22. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298 16 (1978) 869-871
23. Takemura S., Klimiuk P.A., Braun A., Goronzy J.J., and Weyand C.M. T cell activation in rheumatoid synovium is B cell dependent. J Immunol 167 8 (2001) 4710-4718
24. Boackle S.A. Complement and autoimmunity. Biomed Pharmacother 57 7 (2003) 269-273
25. Schroder A.E., Greiner A., Seyfert C., and Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 93 1 (1996) 221-225
26. Berek C., and Kim H.J. B cells in rheumatoid arthritis. Arthritis Res 2 2 (2002) 126-131
27. Ohata J., Zvaifler N.J., Nishio M., Boyle D.L., Kalled S.L., Carson D.A., et al. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol 174 2 (2005) 864-870
28. Terato K., Harper D.S., Griffiths M.M., Hasty D.L., Ye X.J., Cremer M.A., et al. Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity 22 3 (1995) 137-147
29. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., and Brenner M.B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297 5587 (2002) 1689-1692
30. Ronaghy A., Prakken B.J., Takabayashi K., Firestein G.S., Boyle D., Zvailfler N.J., et al. Immunostimulatory DNA sequences influence the course of adjuvant arthritis. J Immunol 168 1 (2002) 51-56
31. Looney R.J., Anolik J., and Sanz I. B cells as therapeutic targets for rheumatic diseases. Curr Opin Rheumatol 16 3 (2004) 180-185